Basel Medical Group (BMGL) Income Statement: Revenue & Earnings

Basel Medical Group Income Statement Analysis

Revenue, earnings, and profit margins in millions SGD

Scale:

Scroll to see more

Basel Medical Group Ltd income statement - Annual data in millions SGD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 2025	Dec 2024	Jun 2023	Jun 2022
Revenue & Gross Profit
Revenue	11.32	11.32	9.75	10.66
Cost of Revenue	2.53	2.53	5.58	2.72
Gross Profit	8.79	8.79	4.16	7.94
Operating Expenses
Research & Development	0.00	0.00	0.00	0.00
Selling, General & Administrative	6.54	6.54	1.05	5.78
Operating Expenses	10.98	10.98	2.16	5.48
Operating Income	-2.18	-2.18	2.00	2.46
Other Income/Expense
Interest Income	0.08	0.08	0.30	0.25
Interest Expense	0.20	0.20	-0.24	-0.32
Other Income/Expense	-10.20	-10.32	0.07	-0.01
Income
Income Before Tax	-12.51	-12.51	2.13	2.39
Income Tax Expense	-0.42	-0.42	0.35	0.41
Net Income	-12.09	-12.09	1.78	1.98
Net Income - Continuous Operations	-12.09	-12.09	1.78	1.98
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00
EBITDA	-11.12	-11.12	2.03	2.48
EBIT	-12.30	2.58	2.00	2.46
Depreciation & Amortization	1.18	1.18	0.03	0.02
Earnings Per Share
Basic EPS	-1.00	-	-	-
Diluted EPS	-1.00	-	-	-
Basic Shares Outstanding	18.79	0.00	16.25	16.25
Diluted Shares Outstanding	18.79	0.00	16.25	16.25